Efficacy and safety of combination therapy of chemoembolization and radiofrequency ablation with different time intervals for hepatocellular carcinoma patients

Combination of transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) has become an effective alternative therapy for hepatocellular carcinoma (HCC). In clinical practice, the choice of time interval between TACE and RFA is a key point for curative effect, but optimal time interval is uncertain in guidelines. We aim to explore the optimal time interval for HCC patients of Child-Pugh classification A or B.

Source: Surgical Oncology - May 3, 2017 Category: Surgery Authors: Yue-min Feng, Xing Wang, Le Wang, Xiao-wen Ma, Hao Wu, Hao-ran Bu, Xiao-yu Xie, Jian-ni Qi, Qiang Zhu Source Type: research